Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-ornithine L-aspartate in Overt Acute Hepatic Encephalopathy
NCT01722578Phase 4Completed
- Sponsor
- Dayanand Medical College & Hospital
- Start
- Dec 2013
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hepatic encephalopathy (HE) comparing L-ornithine L-aspartate with Placebo (2 arms). Primary endpoint: Mental state grade (West Haven Criteria) at 5 days. Started Dec 2013; status: completed.
02
Drugs
l-ornithine l-aspartate
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT01722578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01722578.